Literature DB >> 10097153

Identification of the block in targeted retroviral-mediated gene transfer.

Y Zhao1, L Zhu, S Lee, L Li, E Chang, N W Soong, D Douer, W F Anderson.   

Abstract

A chimeric retroviral vector (33E67) containing a CD33-specific single-chain antibody was generated in an attempt to target cells displaying the CD33 surface antigen. The chimeric envelope protein was translated, processed, and incorporated into viral particles as efficiently as wild-type envelope protein. The viral particles carrying the 33E67 envelope protein could bind efficiently to the CD33 receptor on target cells and were internalized, but no gene transfer occurred. A unique experimental approach was used to examine the basis for this postbinding block. Our data indicate that the chimeric envelope protein itself cannot participate in the fusion process, the most reasonable explanation being that this chimeric protein cannot undergo the appropriate conformational change that is thought to be triggered by receptor binding, a suggested prerequisite to subsequent fusion and core entry. These results indicate that the block to gene transfer in this system, and probably in most of the current chimeric retroviral vectors to date, is the inability of the chimeric envelope protein to undergo this obligatory conformational change.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097153      PMCID: PMC22410          DOI: 10.1073/pnas.96.7.4005

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.

Authors:  S Valsesia-Wittmann; F J Morling; T Hatziioannou; S J Russell; F L Cosset
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 3.  Human gene therapy.

Authors:  W F Anderson
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

4.  Antibody-mediated binding of a murine ecotropic Moloney retroviral vector to human cells allows internalization but not the establishment of the proviral state.

Authors:  B Goud; P Legrain; G Buttin
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

5.  Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.

Authors:  J E Johnson; M J Schnell; L Buonocore; J K Rose
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

6.  Targeting retroviral vectors to CD34-expressing cells: binding to CD34 does not catalyze virus-cell fusion.

Authors:  C A Benedict; R Y Tun; D B Rubinstein; T Guillaume; P M Cannon; W F Anderson
Journal:  Hum Gene Ther       Date:  1999-03-01       Impact factor: 5.695

7.  Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.

Authors:  A Rein; C Yang; J A Haynes; J Mirro; R W Compans
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Entry of murine retrovirus into mouse fibroblasts.

Authors:  K B Andersen; B A Nexø
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

9.  Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein.

Authors:  M M Januszeski; P M Cannon; D Chen; Y Rozenberg; W F Anderson
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  Molecular cloning, expression, and chromosomal localization of a human gene encoding the CD33 myeloid differentiation antigen.

Authors:  S C Peiper; R A Ashmun; A T Look
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

View more
  26 in total

1.  Two point mutations produce infectious retrovirus bearing a green fluorescent protein-SU fusion protein.

Authors:  K Kizhatil; A Gromley; L M Albritton
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.

Authors:  J Overbaugh; A D Miller; M V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

3.  Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.

Authors:  Timothy J Gollan; Michael R Green
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Antibody-directed targeting of retroviral vectors via cell surface antigens.

Authors:  K Morizono; G Bristol; Y M Xie ; S K Kung; I S Chen
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor.

Authors:  S Snitkovsky; T M Niederman; B S Carter; R C Mulligan; J A Young
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 7.  Vectors for gene therapy of cardiovascular disease.

Authors:  J F Dedieu; A Mahfoudi; A Le Roux; D Branellec
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

8.  Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein.

Authors:  E Bachrach; M Marin; M Pelegrin; G Karavanas; M Piechaczyk
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A.

Authors:  Peter M Mazari; Takele Argaw; Leonardo Valdivieso; Xia Zhang; Katherine T Marcucci; Daniel R Salomon; Carolyn A Wilson; Monica J Roth
Journal:  Virology       Date:  2012-03-08       Impact factor: 3.616

10.  Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.

Authors:  Juraj Hlavaty; Anika Stracke; Dieter Klein; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.